These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1981459)

  • 1. Intracellular localization of recombinant vaccinia virus produced HIV antigens and their use for confirmation of HIV seropositivity.
    Bukrinsky MI; Vzorov AN; Bukrinskaya AG
    Acta Virol; 1990 Sep; 34(5):487-92. PubMed ID: 1981459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of blood sera by the immunoblot method using natural and recombinant antigens of the human immunodeficiency virus].
    Bukrinskiĭ MI; Zlobin AIu; Arakelov SA; Popov SA; Chaplinskas SA
    Vopr Virusol; 1988; 33(6):700-3. PubMed ID: 3073570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of gag gene of human immunodeficiency virus in recombinant vaccinia virus].
    Popov SA; Barsov EV; Bukrinskiĭ MI; Zhdanov VM
    Mol Gen Mikrobiol Virusol; 1988 Sep; (9):36-9. PubMed ID: 3264887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells.
    Vzorov AN; Bukrinsky MI; Grigoriev VB; Tentsov YYu ; Bukrinskaya AG
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):29-36. PubMed ID: 1901721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive sera do not react with human immunodeficiency virus (HIV) gag-encoded recombinant antigen.
    Bukrinsky MI; Syrtsev VA; Popov SA; Barsov EV; Chaplinskas SA; Karamov EV
    J Med Virol; 1989 Jan; 27(1):72-5. PubMed ID: 2466101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus].
    Vzorov AN; Tentsov IuIu; Grigor'ev VB; Shulenin SA; Garaev MM; Bogdan OP; Bukrinskaia AG
    Mol Biol (Mosk); 1990; 24(6):1666-74. PubMed ID: 2094814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
    Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E. coli antibodies do not cause false-positivity in recombinant anti-HIV assays.
    Ujhelyi E; Illei G; Böhm U; Füst G; Dierich MM; Szelényi J; Merétey K; Hofbauer J; Hollán SR
    Haematologia (Budap); 1990; 23(1):3-7. PubMed ID: 2204595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
    Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
    Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
    Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
    J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
    Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
    Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 core proteins expressed from recombinant vaccinia viruses.
    Rautmann G; Kieny MP; Brandely R; Dott K; Girard M; Montagnier L; Lecocq JP
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):147-57. PubMed ID: 2713165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H; Wakabayashi A; Shimizu M; Kaneko H; Norose Y; Nakagawa Y; Wang J; Kumagai Y; Margulies DH; Takahashi H
    Biochem Biophys Res Commun; 2004 Apr; 316(2):356-63. PubMed ID: 15020225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in diagnosing HIV infections.
    Wilber JC
    AIDS Clin Rev; 1991; ():1-15. PubMed ID: 1868004
    [No Abstract]   [Full Text] [Related]  

  • 20. Confirmation of HIV seropositivity: comparison of a novel radioimmunoprecipitation assay to immunoblotting and virus culture.
    Tersmette M; Lelie PN; van der Poel CL; Wester MR; de Goede RE; Lange JM; Miedema F; Huisman JG
    J Med Virol; 1988 Jan; 24(1):109-16. PubMed ID: 2828529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.